Related Experiment Video
Updated: Jul 26, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Role of G-protein coupled receptors in cardiovascular diseases
Yuanqiang Li1, Boyu Li2, Wei-Dong Chen3,4
1State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Insights
G-protein-coupled receptors (GPCRs) are crucial in cardiovascular diseases (CVDs), influencing heart and vascular functions. Understanding GPCRs offers new therapeutic targets for treating these widespread conditions.
Area of Science:
- Pharmacology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of mortality, responsible for approximately 30% of annual deaths worldwide.
- G-protein-coupled receptors (GPCRs) are integral cell surface receptors critical for regulating physiological and pathological cellular processes.
- Existing CVD treatments, including beta-blockers, and a significant portion of cardiovascular drugs target GPCRs, highlighting their therapeutic importance.
Purpose of the Study:
- To review and discuss the multifaceted roles of GPCRs in cardiovascular system function, encompassing both vascular and cardiac perspectives.
- To analyze the complex regulatory mechanisms of multiple GPCRs in the context of vascular and heart diseases.
- To identify novel therapeutic strategies and drug development opportunities for CVDs based on GPCR research.
Main Methods:
- Literature review and synthesis of existing research on GPCR structure and function in cardiovascular contexts.
- Analysis of data linking GPCR activity to cardiovascular physiology and pathology.
- Exploration of therapeutic interventions targeting GPCRs for CVD treatment.
Main Results:
- GPCRs play a pivotal role in regulating cardiovascular system functions, affecting both the heart and vasculature.
- Evidence indicates that numerous GPCRs are implicated in the development and progression of various cardiovascular diseases.
- Targeting GPCRs has proven effective in current CVD therapies and represents a significant area for future drug development.
Conclusions:
- GPCRs are indispensable regulators of cardiovascular health and disease.
- A comprehensive understanding of GPCRs in cardiovascular diseases is essential for advancing treatment options.
- This review provides a foundation for developing innovative drugs targeting GPCRs to combat cardiovascular diseases effectively.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of death globally, with CVDs accounting for nearly 30% of deaths worldwide each year. G-protein-coupled receptors (GPCRs) are the most prominent family of receptors on the cell surface, and play an essential regulating cellular physiology and pathology. Some GPCR antagonists, such as β-blockers, are standard therapy for the treatment of CVDs. In addition, nearly one-third of the drugs used to treat CVDs target GPCRs. All the evidence demonstrates the crucial role of GPCRs in CVDs. Over the past decades, studies on the structure and function of GPCRs have identified many targets for the treatment of CVDs. In this review, we summarize and discuss the role of GPCRs in the function of the cardiovascular system from both vascular and heart perspectives, then analyze the complex ways in which multiple GPCRs exert regulatory functions in vascular and heart diseases. We hope to provide new ideas for the treatment of CVDs and the development of novel drugs.
Related Concept Videos
G-protein Coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-Protein Gated Ion Channels
Sensory...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

